miR-194 targets heparin-binding EGF-like growth factor (HBEGF) gene which impairs the phosphorylation of ERBB2/B4 tyrosine kinase receptors and in turn leads to severe DCM [67]. The gene discussed is NTRK1; the disease is familial dilated cardiomyopathy.